China's Gene Invention Patent Application Increases by 26%
2009/06/10
On June 2, Summit Forum on Chinese Gene Science and Industry Development was held in Beijing, with the participation of Vice Chairman of the Chinese People's Political Consultative Conference Wang Zhizhen and Member of the Standing Committee of the National People's Congress Yang Bangjie.
Vice Commissioner of the State Intellectual Property Office (SIPO) Zhang Qin said when attending the forum, from the year 2004 to 2008, China witnessed an annual rise of domestic gene invention patent applications of 26%.
In recent years, China's independent research and development capability in the field of gene has been significantly enhanced. According to statistics, in past five years, the average increase rate of domestic gene invention patent applications received by SIPO is 26.4%, and the foreign one is 17.8%.
In 2008, 4,532 pieces of patent application of this kind were received, in which domestic applications are 3,410, accounting for 75.2 percent of total applications; and only 1,321 pieces were granted, including 945 domestic ones, with the average growth rate of 16.3% among past five years, which is higher than the number of applications abroad.
However, the distribution of domestic patents is not balanced. The top ten among gene invention patent applications are eight universities and two scientific research institutions during past 5 years, Zhang added.
Therefore, the nation should elevate IP-related creation, use, protection and management level, promote the development of China's gene industry, encourage domestic innovation-oriented enterprises to obtain independent intellectual property rights, and urge them to carry out PCT patent applications.
In addition, we must perfect the construction of relevant laws and regulations, enhance intellectual property management work of bio-industry bases, strengthen the combination among industries, universities and research institutes, build up an early warning and response mechanism for gene patents and protect the healthy development of research and industry.
It is learnt that a total of more than 400 representatives from National Development and Reform Commission, General Administration of Quality Supervision, Inspection and Quarantine and some enterprises attended the forum.
Source: IPR in China
京公网安备 11010802020770号